Animal & Veterinary

Swine


Breeding Swine
Feral Swine
Finishing Swine
Growing Swine
Piglets
Swine


Marketing Status The following guide explains the marketing status categories used in the tables below:

  • OTC - Product is in over-the-counter marketing status and is not impacted by Guidance for Industry #213 (GFI #213)
  • VFD - Product is in Veterinary Feed Directive Status.

Breeding Swine

Active IngredientProprietary NameNADA/ANADALabel TypeIndicationsMarketing Status
Bacitracin Methylene DisalicylateBMD 30N046-592Type BFor control of clostridial enteritis caused by Clostridium perfringens in suckling piglets when fed to sows from 14 days before through 21 days after farrowing on premises with a history of clostridial scours.OTC
Bacitracin Methylene DisalicylateBMD 30N046-592Type CFor control of clostridial enteritis caused by Clostridium perfringens in suckling piglets when fed to sows from 14 days before through 21 days after farrowing on premises with a history of clostridial scours.OTC
ChlortetracyclineCHLORMAXN046-699Type CBreeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineCHLORATETN048-480Type BBreeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of Leptospirae) caused by Leptospira pomona susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineCHLORATETN048-480Type CBreeding swine: For control of leptospirosis (reducing the incidence of abortion and shedding of Leptospirae) caused by Leptospira pomona susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineAUREOMYCINN048-761Type BFor control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine.VFD (Effective 1/1/17)
ChlortetracyclineAUREOMYCINN048-761Type CFor control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine.VFD (Effective 1/1/17)
ChlortetracyclineCLTCN092-286Type CFor breeding swine for control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineDERACINA200-510Type BFor control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine.VFD (Effective 1/1/17)
ChlortetracyclineDERACINA200-510Type CFor control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine.VFD (Effective 1/1/17)
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type CFor the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For control of clostridial enteritis caused by C. perfringens in suckling piglets. 
OTC
Neomycin Sulfate and OxytetracyclineNEO-OXTCN138-939Type CFor control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.VFD (Effective 1/1/17)

Back to the top

Feral Swine

Active IngredientProprietary NameNADA/ANADALabel TypeIndicationsMarketing Status
Fenbendazole SAFE-GUARDN131-675Type C For the control and removal of kidney worms (Stephanurus dentatus), round worms (Ascaris suum), and nodular worms (Oesophagostomum dentatum)OTC

Back to the top

 Finishing Swine

Active IngredientProprietary NameNADA/ANADALabel TypeIndicationsMarketing Status
Ractopamine and TylosinPAYLEAN, TYLANN141-172Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLANN141-172Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; and for control of porcine proliferative enteropathies  associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLANN141-172Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLANN141-172Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, ...; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLANN141-172Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs... and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLANN141-172Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs...; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLOVETA200-530Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferafive enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLOVETA200-530Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLOVETA200-530Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLOVETA200-530Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLOVETA200-530Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEAN, TYLOVETA200-530Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLANA200-558Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLANA200-558Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLANA200-558Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLANA200-558Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLANA200-558Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLANA200-558Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLOVETA200-584Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLOVETA200-584Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLOVETA200-584Type BFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for the treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLOVETA200-584Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for treatment and control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLOVETA200-584Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter; for control of swine dysentery associated with Brachyspira hyodysenteriae; and for control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinENGAIN, TYLOVETA200-584Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine, weighing not less than 150 lbs, fed a complete ration containing at least 16% crude protein for the last 45 to 90 lbs of gain prior to slaughter, and for control of porcine proliferative enteropathies (PPE, ileitis) associated with
Lawsonia intracellularis.
VFD (Effective 1/1/17)

Back to the top

Growing Swine

Active IngredientProprietary NameNADA/ANADALabel TypeIndicationsMarketing Status
ChlortetracyclineCHLORMAXN046-699Type CFor an increased rate of weight gain and improved feed efficiency in growing swine.As of 1/1/17, this use is no longer approved
ChlortetracyclineAUREOMYCINN048-761Type BFor increased rate of weight gain and improved feed efficiency in growing swine.As of 1/1/17, this use is no longer approved
ChlortetracyclineAUREOMYCINN048-761Type CFor increased rate of weight gain and improved feed efficiency in growing swine.As of 1/1/17, this use is no longer approved

Back to the top

Piglets

Active IngredientProprietary NameNADA/ANADALabel TypeIndicationsMarketing Status
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type BFor the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, threadworms, lice and mange mites.
For control of clostridial enteritis caused by C. perfringens in suckling piglets.
OTC

Back to the top

Swine

Active IngredientProprietary NameNADA/ANADALabel TypeIndicationsMarketing Status/Posting Date
ApramycinAPRALANN126-050Type CFor control of porcine colibacillosis (weanling pig scours) caused by susceptible strains of Escherichia coli.VFD (Effective 1/1/17)
AvilamycinKAVAULTN141-438Type CFor the reduction in incidence and overall severity of diarrhea in the presence of pathogenic
Escherischia coli in groups of weaned pigs.
VFD
Bacitracin Methylene DisalicylateBMDN046-592Type BFor increased rate of weight gain and improved feed efficiency in growing and finishing swine.OTC
Bacitracin Methylene DisalicylateBMDN046-592Type CFor increased rate of weight gain and improved feed efficiency in growing and finishing swine.OTC
Bacitracin Methylene DisalicylateBMDN046-592Type BFor control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of the disease have not yet occurred; or following an approved treatment of the disease condition in growing and finishing swine weighing up to 250 pounds.OTC
Bacitracin Methylene DisalicylateBMDN046-592Type CFor control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of the disease have not yet occurred; or following an approved treatment of the disease condition in growing and finishing swine weighing up to 250 pounds.OTC
Bacitracin ZincALBACA200-223Type BFor increased rate of weight gain and improved feed efficiency in growing and finishing swine.OTC
Bacitracin ZincALBACA200-223Type CFor increased rate of weight gain and improved feed efficiency in growing and finishing swine.OTC
CarbadoxMECADOXN041-061Type BFor control of swine dysentery (vibrionic dysentery, bloody scours by hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency.OTC
CarbadoxMECADOXN041-061Type BFor increased rate of weight gain and improved feed efficiency.OTC
CarbadoxMECADOXN041-061Type CFor control of swine dysentery (vibrionic dysentery, bloody scours of hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); increased rate of weight gain and improved feed efficiency.OTC
CarbadoxMECADOXN041-061Type CFor increased rate of weight gain and improved feed efficiency.OTC
Carbadox and OxytetracyclineMECADOX, TERRAMYCINN141-211Type CFor treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline and increased rate of weight gain and improved feed efficiency.VFD (Effective 1/1/17)
Carbadox and Pyrantel tartrateMECADOX, BANMINTHN092-955Type CControl of swine dysentery (vibrionic dysentery, bloody scours or hemorrhagic dysentery); control of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis); aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections in swine.OTC
ChlortetracyclineCHLORMAXN046-699Type BFor control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis... For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms.VFD (Effective 1/1/17)
ChlortetracyclineCHLORMAXN046-699Type CFor reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci.VFD (Effective 1/1/17)
ChlortetracyclineCHLORMAXN046-699Type CFor control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis...For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida organisms.VFD (Effective 1/1/17)
ChlortetracyclineAUREOMYCINN048-761Type BFor control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineAUREOMYCINN048-761Type CFor control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineAUREOMYCINN048-761Type BFor reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine.VFD (Effective 1/1/17)
ChlortetracyclineAUREOMYCINN048-761Type CFor reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine.VFD (Effective 1/1/17)
ChlortetracyclineCHLORATETN048-480Type BTreatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineCHLORATETN048-480Type CTreatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineCHLORATETN048-480Type BFor reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracyclineVFD (Effective 1/1/17)
ChlortetracyclineCHLORATETN048-480Type CFor reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracyclineVFD (Effective 1/1/17)
ChlortetracyclineCLTCN092-286Type CFor swine for treatment of bacterial enteritis caused by  E. coli and S. choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracyclineVFD (Effective 1/1/17)
ChlortetracyclineCLTCN092-286Type CFor swine for reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclinePENNCHLORN138-935Type BFor use in manufacturing medicated swine feed.VFD (Effective 1/1/17)
ChlortetracyclinePENNCHLORN138-935Type CFor reducing the incidence of cervical lymphadenitis (jowl abscesses caused by  Group E. Streptococci susceptible to chlortetracyclineVFD (Effective 1/1/17)
ChlortetracyclinePENNCHLORN138-935Type CFor the treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclinePENNCHLORN138-935Type CFor the control of leptospirosis (reducing the incidence of abortions and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline in breeding swine.VFD (Effective 1/1/17)
ChlortetracyclineDERACINA200-510Type BFor control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by  Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineDERACINA200-510Type CFor control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. For treatment of bacterial enteritis caused by  Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
ChlortetracyclineDERACINA200-510Type BFor reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine.VFD (Effective 1/1/17)
ChlortetracyclineDERACINA200-510Type CFor reduction in the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline in swine.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylateBMD, CHLORMAXN141-059Type BFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylateBMD, CHLORMAXN141-059Type BFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylateBMD, CHLORMAXN141-059Type CFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylateBMD, AUREOMYCINA200-242Type BFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylateBMD, AUREOMYCINA200-242Type BFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylateBMD, AUREOMYCINA200-242Type CFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylatePENNCHLOR, BMDA200-358Type BFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline, and for control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracyline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylatePENNCHLOR, BMDA200-358Type BFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
Chlortetracycline and Bacitracin Methylene DisalicylatePENNCHLOR, BMDA200-358Type CFor increased rate of weight gain and improved feed efficiency; for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline.VFD (Effective 1/1/17)
Chlortetracycline and SulfamethazineAUREOMIXN035-688Type BFor reduction of the incidence of cervical abscesses; treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of these diseases during times of stress; and maintenance of weight gains in the presence of atrophic rhinitis.VFD (Effective 1/1/17)
Chlortetracycline and SulfamethazineAUREOMIXN035-688Type CFor reduction of the incidence of cervical abscesses; treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of these diseases during times of stress; and maintenance of weight gains in the presence of atrophic rhinitis.VFD (Effective 1/1/17)
Chlortetracycline and SulfamethazinePENNCHLORN138-934Type BFor reduction of the incidence of cervical abscesses, treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery) during time of stress; maintenance of weight gains in the presence of atrophic rhinitis.VFD (Effective 1/1/17)
Chlortetracycline and SulfamethazinePENNCHLORN138-934Type BFor reduction of the incidence of cervical abscesses, treatment of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery); prevention of bacterial swine enteritis (salmonellosis or necrotic enteritis caused by Salmonella choleraesuis and vibrionic dysentery) during time of stress; maintenance of weight gains in the presence of atrophic rhinitis.VFD (Effective 1/1/17)
FlorfenicolNUFLORN141-264Type BFor the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis, and Bordetella bronchiseptica in groups of swine in buildings experiencing an outbreak of SRD.VFD
FlorfenicolNUFLORN141-264Type CFor the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Streptococcus suis, and Bordetella bronchiseptica in groups of swine in buildings experiencing an outbreak of SRD.VFD
HygromycinHYGROMIXN010-918Type BAs an aid in the control of infections of the following intestinal parasites: Large roundworms (Ascaris suis), nodular worms (Oesophagostomum dentatum), and whipworms (Trichuris suis).VFD (Effective 1/1/17)
HygromycinHYGROMIXN010-918Type CAs an aid in the control of infections of the following intestinal parasites: Large roundworms (Ascaris suis), nodular worms (Oesophagostomum dentatum), and whipworms (Trichuris suis).VFD (Effective 1/1/17)
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type CFor the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, threadworms, lice and mange mites.
For increased rate of weight gain and improved feed efficiency in growing finishing swine.
OTC
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type BFor the treatment and control of gastrointestinal roundworms, kidneyworms, lice, and mange mites.
For increased rate of weight gain and improved feed efficiency in growing and finishing swine.
OTC
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type BFor the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For increased rate of weight gain and improved feed efficiency in growing and finishing swine.
OTC
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type CFor the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of disease have not yet occurred; or following an approved treatment of the disease condition.
OTC
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type CFor the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For increased rate of weight gain and improved feed efficiency in growing and finishing swine. 
OTC
Ivermectin, Bacitracin Methylene DisalicylateBMD, IVOMECN141-097Type BFor the treatment and control of gastrointestinal roundworms, kidneyworms, lungworms, lice, and mange mites.
For control of swine dysentery associated with Treponema hyodysenteriae on premises with a history of swine dysentery but where signs of the disease have not yet occurred; or following an approved treatment of the disease condition.
OTC
Ivermectin and LincomycinIVOMEC, LINCOMIXN141-054Type C

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis). 

Treatment of swine dysentery.

VFD (Effective 1/1/17)
Ivermectin, LincomycinIVOMEC, LINCOMIXN141-054Type BFor the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).
For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae.
VFD (Effective 1/1/17)
Ivermectin, LincomycinIVOMEC, LINCOMIXN141-054Type B

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).

For control of swine dysentery

VFD (Effective 1/1/17)
Ivermectin, LincomycinIVOMEC, LINCOMIXN141-054Type CFor the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae.VFD (Effective 1/1/17)
Ivermectin, LincomycinIVOMEC, LINCOMIXN141-054Type C

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).

Control of swine dysentery; for use in swine on premises with a history of swine dysentery, but where symptoms have not yet occurred.

VFD (Effective 1/1/17)
Ivermectin, LincomycinIVOMEC, LINCOMIXN141-054Type B

For the treatment and control of gastrointestinal roundworms (Ascaris suum, adults and fourth-stage larvae; Ascarops strongylina, adults; Hyostrongylus rubidus, adults and fourth-stage larvae; Oesophagostomum spp., adults and fourth-stage larvae), kidneyworms (Stephanurus dentatus, adults and fourth-stage larvae), lungworms (Metastrongylus spp., adults), lice (Haematopinus suis) and mange mites (Sarcoptes scabiei var. suis).

For the treatment and control of swine dysentery.

VFD (Effective 1/1/17)
LincomycinLINCOMIXN097-505Type CFor reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae.VFD (Effective 1/1/17)
LincomycinLINCOMIXN097-505Type BFor the treatment and control of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis. For reduction in the severity of swine mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. .VFD (Effective 1/1/17)
Lincomycin (Swine Ration L100)LINCOMIXN097-505Type CFor treatment of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis.VFD (Effective 1/1/17)
Lincomycin (Swine Ration LC)LINCOMIXN097-505Type CFor control of swine dysentery and the control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis.VFD (Effective 1/1/17)
Lincomycin (Swine Ration L20)LINCOMIXN097-505Type C For increase in rate of weight gain in growing-finishing swine.As of 1/1/17, this use is no longer approved
Lincomycin and FenbendazoleLINCOMIX, SAFE-GUARDN140-954Type CFENBENDAZOLE IS INDICATED FOR THE REMOVAL OF:
Lungworms: Metastrongylus apri, Metastrongylus pudendotectus
Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Adult and larvae (L2, 3, 4 stages - intestinal mucosal forms) whipworm (Trichuris suis)
Kidney worm: Adult and larvae Stephanurus dentatus.
LINCOMYCIN IS INDICATED FOR: for reduction in the severity of swine mycoplasma pneumonia caused by Mycoplasma hyopneumoniae.
VFD (Effective 1/1/17)
Lincomycin and FenbendazoleLINCOMIX, SAFE-GUARDN140-954Type CFENBENDAZOLE IS INDICATED FOR THE REMOVAL OF:
Lungworms: Metastrongylus apri, Metastrongylus pudendotectus
Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Adult and larvae (L2, 3, 4 stages - intestinal mucosal forms) whipworm (Trichuris suis)
Kidney worm: Adult and larvae Stephanurus dentatus.
LINCOMYCIN IS INDICATED FOR: treatment of swine dysentery.
VFD (Effective 1/1/17)
Lincomycin and FenbendazoleLINCOMIX, SAFE-GUARDN140-954Type C

FENBENDAZOLE IS INDICATED FOR THE REMOVAL OF:
Lungworms: Metastrongylus apri, Metastrongylus pudendotectus
Gastrointestinal worms: Adult and larvae (L3, L4 stages, liver, lung, intestinal forms) large roundworm (Ascaris suum); nodular worms (Oesophagostomum dentatum, O. quadrispinulatum); small stomach worm (Hyostrongylus rubidus); Adult and larvae (L2, 3, 4 stages - intestinal mucosal forms) whipworm (Trichuris suis)
Kidney worm: Adult and larvae Stephanurus dentatus.

LINCOMYCIN IS INDICATED FOR: control of swine dysentery; for use in swine on premises with a history of swine dysentery, but where symptoms have not yet occurred.

VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrateBANMINTH, LINCOMIXN116-044Type BFor control of swine dysentery. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections of swine.VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrateBANMINTH, LINCOMIXN116-044Type BFor treatment of swine dysentery. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp.) infections of swine.VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrateBANMINTH, LINCOMIXN116-044Type CFor treatment and/or control of swine dysentery; for removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum spp.) infections.VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrateBANMINTH, LINCOMIXN116-044Type CFor treatment and/or control of swine dysentery; for removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum spp.) infections.VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrateBANMINTH, LINCOMIXN138-941Type BFor reduction in the severity of mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp) infections of swine when fed in accordance with directions for use.VFD (Effective 1/1/17)
Lincomycin and Pyrantel tartrateBANMINTH, LINCOMIXN138-941Type CFor reduction in the severity of mycoplasmal pneumonia caused by Mycoplasma hyopneumoniae. Aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum spp) infections of swine when fed in accordance with directions for use.VFD (Effective 1/1/17)
Neomycin Sulfate and OxytetracyclineNEO-TERRAMYCINN094-975Type BTreatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline
VFD (Effective 1/1/17)
Neomycin Sulfate and OxytetracyclineNEO-TERRAMYCINN094-975Type CTreatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline
VFD (Effective 1/1/17)
Neomycin Sulfate and OxytetracyclineNEO-OXYN138-939Type BFor increased rate of weight gain and improved feed efficiency....treatment and control of bacterial enteritis...and bacterial pneumonia...treatment and control of colibacillosis...control and treatment of leptospirosis...VFD (Effective 1/1/17)
Neomycin Sulfate and OxytetracyclineNEO-OXYN138-939Type CFor increased rate of weight gain and improved feed efficiency.As of 1/1/17, this use is no longer approved
Neomycin Sulfate and OxytetracyclineNEO-OXYN138-939Type CFor treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis...VFD (Effective 1/1/17)
OxytetracyclineTERRAMYCINN008-804Type B

Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline

For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline

VFD (Effective 1/1/17)
OxytetracyclineTERRAMYCINN008-804Type C

Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline

For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline

VFD (Effective 1/1/17)
OxytetracyclineOXTCN095-143Type BFor swine for increased rate of weight gain and improved feed efficiency.As of 1/1/17, this use is no longer approved
OxytetracyclineOXTCN095-143Type CFor swine for increased rate of weight gain and improved feed efficiency.As of 1/1/17, this use is no longer approved
OxytetracyclineOXTCN095-143Type BFor swine for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.
VFD (Effective 1/1/17)
OxytetracyclineOXTCN095-143Type CFor swine for treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis susceptible to oxytetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline.
For breeding swine for control and treatment of Leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.
VFD (Effective 1/1/17)
OxytetracyclineOTCN138-938Type BFor increased rate of weight gain and improved feed efficiency; treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida; control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona.VFD (Effective 1/1/17)
OxytetracyclineOTCN138-938Type CFor increased rate of weight gain and improved feed efficiency.As of 1/1/17, this use is no longer approved
OxytetracyclineOTCN138-938Type CFor treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida.VFD (Effective 1/1/17)
OxytetracyclineOTCN138-938Type CFor control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline.VFD (Effective 1/1/17)
Pyrantel tartrateBAN-A-WORMN043-290Type B

For the removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum) infections in swine.

To aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum) infections in swine.

For the removal and control of large roundworm (Ascaris suum) infections in swine.

OTC
Pyrantel tartrateBAN-A-WORMN043-290Type C

For the removal and control of large roundworm (Ascaris suum) and nodular worm (Oesophagostomum) infections in swine.

To aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; aid in the prevention of establishment of nodular worm (Oesophagostomum) infections in swine.

For the removal and control of large roundworm (Ascaris suum) infections in swine.

OTC
Ractopamine and TylosinPAYLEANN141-172Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine...; control of swine dysentery associated with Brachyspira hyodysenteriae; and control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
Ractopamine and TylosinPAYLEANN141-172Type CFor increased rate of weight gain, improved feed efficiency and increased carcass leanness in finishing swine...; and control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
TiamulinDENAGARDN139-472Type BFor control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis; control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin.OTC
TiamulinDENAGARDN139-472Type CFor control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis and for control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin; treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin.OTC
TiamulinDENAGARDN139-472Type C - 35 g/tonFor control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin.OTC
TiamulinDENAGARDN139-472Type C - 200 g/tonFor control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin.OTC
TiamulinDENAGARDN139-472Type CFor control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis.OTC
Tiamulin, ChlortetracyclineDENAGARD, CTCN141-011Type CFor the control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin and for treatment of swine bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis sensitive to chlortetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida sensitive to chlortetracycline.VFD (Effective 1/1/17)
Tiamulin, ChlortetracyclineDENAGARD, PENNCHLORA200-356Type CFor control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to tiamulin and for treatment of swine bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis sensitive to chlortetracycline and treatment of bacterial pneumonia caused by Pasteurella multocida sensitive to chlortetracycline.VFD (Effective 1/1/17)
TilmicosinPULMOTILN141-064Type CFor the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida.VFD
TilmicosinPULMOTILN141-064Type BFor the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida.VFD
TilmicosinTILMOVETA200-509Type BFor the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida.VFD
TilmicosinTILMOVETA200-509Type CFor the control of swine respiratory disease associated with Actinobacillus pleuropneumoniae and Pasteurella multocida.VFD
TylosinTYLANN012-491Type BFor treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLANN012-491Type CFor treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLANN012-491Type BFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLANN012-491Type CFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLANN012-491Type BFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
TylosinTYLANN012-491Type CFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
TylosinTYLANN012-491Type BFor control of swine dysentery associated with Brachyspira hyodysenteriaeVFD (Effective 1/1/17)
TylosinTYLANN012-491Type CFor control of swine dysentery associated with Brachyspira hyodysenteriaeVFD (Effective 1/1/17)
TylosinTYLANN012-491Type BFor reduction in severity of effects of atrophic rhinitisVFD (Effective 1/1/17)
TylosinTYLANN012-491Type CFor reduction in severity of effects of atrophic rhinitisVFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type BFor the reduction in severity of effects of atrophic rhinitis.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type CFor the reduction in severity of effects of atrophic rhinitis.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type BFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type BFor treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type CFor treatment and control of swine dysentery associated with Brachyspira hyodysenteriae immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type BFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type CFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis immediately after medicating with tylosin in drinking water.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type CFor control of porcine proliferative enteropathies (PPE, ileitis) associated with Lawsonia intracellularis.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type BFor control of swine dysentery associated with Brachyspira hyodysenteriae.VFD (Effective 1/1/17)
TylosinTYLOVETA200-484Type CFor control of swine dysentery associated with Brachyspira hyodysenteriae.VFD (Effective 1/1/17)
Tylosin and PyrantelTYLAN, BANMINTHN110-047Type CFor treatment and control of swine dysentery (vibrionic) immediately after medicating with tylosin in drinking water; aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; and as an aid in the prevention of establishment of nodular worm (Oesophagostomum) infections.VFD (Effective 1/1/17)
Tylosin and PyrantelTYLAN, BANMINTHN110-047Type CFor prevention of swine dysentery (vibrionic); aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; and as aid in the prevention of establishment of nodular worm (Oesophagostumum) infections.VFD (Effective 1/1/17)
Tylosin and PyrantelTYLAN, BANMINTHN110-047Type CFor prevention of swine dysentery (vibrionic); aid in the prevention of migration and establishment of large roundworm (Ascaris suum) infections; and as an aid in the.
prevention of establishment of nodular worm (Oesophagostomum) infections.
VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN041-275Type BFor reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of Bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes);
Reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci. Only the sulfamethazine portion of this combination is active in controlling jowl abscesses.
VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN041-275Type CReducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci. Only the sulfamethazine portion of this combination is active in controlling jowl abscesses.VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN041-275Type CFor prevention of swine dysentery associated with Brachyspira hyodysenteriaeVFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN041-275Type CFor control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes).VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN041-275Type CFor lowering the incidence and severity of Bordetella bronchiseptica rhinitisVFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN041-275Type CFor reduction in the severity of effects of atrophic rhinitis.VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN091-749Type BFor reduction in the severity of effects of atrophic rhinitis; lowering the incidence and severity of Bordetella bronchiseptica rhinitis; prevention of swine dysentery associated with Brachyspira hyodysenteriae; and control of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes.)VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN091-749Type CFor lowering the incidence and severity of Bordetella bronchiseptica rhinitis.VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN091-749Type CPrevention of swine dysentery associated with Brachyspira hyodysenteriae.VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN091-749Type CFor reduction in the severity of effects of atrophic rhinitis.VFD (Effective 1/1/17)
Tylosin and SulfamethazineTYLAN, SULFA-GN091-749Type CControl of swine pneumonias caused by bacterial pathogens (Pasteurella multocida and/or Arcanobacterium pyogenes.)VFD (Effective 1/1/17)
TylvalosinAIVLOSINN141-460Type BControl of porcine proliferative enteropathy (FPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPEVFD
TylvalosinAIVLOSINN141-460Type CControl of porcine proliferative enteropathy (FPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPEVFD
VirginiamycinSTAFACN091-467Type BIncreased rate of weight gain and improved feed efficiency; aid in the control of swine dysentery... for use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred; treatment and control of swine dysentery.VFD (Effective 1/1/17)
VirginiamycinSTAFACN091-467Type CIncreased rate of weight gain and improved feed efficiency...As of 1/1/17, this use is no longer approved.
VirginiamycinSTAFACN091-467Type CAs an aid in the control of swine dysentery in swine weighing up to 120 lb.  For use in animals or on premises with a history of swine dysentery, but where symptoms have not yet occurred.VFD (Effective 1/1/17)
VirginiamycinSTAFACN091-467Type CFor treatment and control of swine dysentery in swine weighing up to 120 lb.VFD (Effective 1/1/17)
VirginiamycinSTAFACN091-467Type CFor treatment and control of swine dysentery in non-breeding swine weighing over 120 lb.VFD (Effective 1/1/17)
VirginiamycinSTAFACN091-467Type CIncreased rate of weight gain and improved feed efficiency...As of 1/1/17, this use is no longer approved.

Back to the top

Page Last Updated: 01/12/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English